Loading clinical trials...
Loading clinical trials...
A Randomized Clinical Trial to Define the Best Strategy for the Management of Heart Failure and Chronic Kidney Disease Among Elderly Patients With or at High Risk of hyperKalemia in Span by Optimizing the Use of RAASi With SZC
Conditions
Interventions
Sodium Zirconium Cyclosilicate
Standard of care treatment (RAASi therapy)
Locations
6
Spain
Hospital Universitario Fundación Alcorcón
Alcorcón, Madrid, Spain
Hospital Universitario Severo Ochoa
Leganés, Madrid, Spain
Hospital Universitario Nuestra Señora del Perpétuo Socorro
Albacete, Spain
Hospital Universitario de Burgos
Burgos, Spain
Hospital Universitario Reina Sofía
Córdoba, Spain
Hospital Clínico Universitario de Valencia
Valencia, Spain
Start Date
October 3, 2024
Primary Completion Date
December 30, 2026
Completion Date
December 30, 2026
Last Updated
March 4, 2026
NCT07083011
NCT07550790
NCT07037459
NCT06874556
NCT06741436
NCT07318103
Lead Sponsor
Fundación para la Investigación del Hospital Clínico de Valencia
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions